Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid antibody syndrome]

F Moccia1, G Greco

  • 1Dipartimento d'Emergenza, Ospedale S. Martino, Genova.

La Clinica Terapeutica
|July 1, 1994
PubMed
Summary

Antiphospholipid antibody syndrome (APS) can occur with Systemic Lupus Erythematosus or as a primary condition. It involves thrombosis, pregnancy loss, or low platelets, diagnosed by specific antibodies and leading to endothelial damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

The effect of different structural decoration geometries on vibration propagation in spider orb webs.

PloS one·2025
Same author

Thermionic emission conduction in Mo AlGaN/GaN diodes in the presence of Schottky barrier inhomogeneities.

Scientific reports·2025
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of "Rete Ematologica Pugliese" (REP).

Leukemia research reports·2025
Same author

Therapeutic approach to fibromyalgia: a consensus statement on pharmacological and non-pharmacological treatment from the neuropathic pain special interest group of the Italian neurological society.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025

Area of Science:

  • Immunology
  • Rheumatology
  • Hematology

Background:

  • Antiphospholipid antibody syndrome (APS) is a condition that can arise secondary to Systemic Lupus Erythematosus (SLE) or as a primary autoimmune disorder.
  • Primary APS lacks the clinical and serological markers of SLE, presenting uniquely.

Purpose of the Study:

  • To outline the characteristics and diagnostic criteria of primary APS.
  • To review the underlying mechanisms of thrombosis in APS.
  • To summarize current and alternative therapeutic strategies for APS.

Main Methods:

  • Review of existing literature on antiphospholipid antibody syndrome.
  • Analysis of clinical manifestations and laboratory findings associated with APS.
  • Evaluation of proposed pathogenic mechanisms for thrombosis in APS.
  • Compilation of data on therapeutic interventions for APS.

Main Results:

  • Primary APS is defined by clinical events (thromboembolism, pregnancy loss, thrombocytopenia) and laboratory evidence of antiphospholipid antibodies (aPLs), including anticardiolipin antibodies and lupus anticoagulant.
  • Thrombosis in APS is attributed to endothelial damage, not vasculitis, with multiple proposed mechanisms.
  • Standard therapy involves anticoagulants (dicumarol, heparin) combined with prednisone.

Conclusions:

  • APS presents with distinct clinical and laboratory features, requiring specific diagnostic approaches.
  • Understanding the thrombotic mechanisms is crucial for effective management.
  • Treatment options range from conventional anticoagulation and corticosteroids to more intensive therapies like immunoglobulins, plasmapheresis, and cyclophosphamide for severe cases.

Related Experiment Videos